Cargando…
β1 Adrenergic Receptor Polymorphisms and Heart Failure: A Meta-Analysis on Susceptibility, Response to β-Blocker Therapy and Prognosis
AIMS: The risk stratification of patients for heart failure (HF) remains a challenge, as well as the anticipation of the response to β-blocker therapy. Since the pivotal role of β1 adrenergic receptor (β1-AR) in HF, many publications have studied the associations between the β1-AR polymorphisms (Ser...
Autores principales: | Liu, Wen-Nan, Fu, Kai-Li, Gao, Hai-Yang, Shang, Yuan-Yuan, Wang, Zhi-Hao, Jiang, Gui-Hua, Zhang, Yun, Zhang, Wei, Zhong, Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398943/ https://www.ncbi.nlm.nih.gov/pubmed/22815685 http://dx.doi.org/10.1371/journal.pone.0037659 |
Ejemplares similares
-
A meta-analysis of the effects of β-adrenergic blockers in chronic heart failure
por: Zhang, Xiaojian, et al.
Publicado: (2016) -
β blockers for heart failure
por: Hoes, Arno W
Publicado: (2016) -
Adrenergic receptor genotype influences heart failure severity and β-blocker response in children with dilated cardiomyopathy
por: Reddy, Sushma, et al.
Publicado: (2015) -
Impact of the β-1 adrenergic receptor polymorphism on tolerability and efficacy of bisoprolol therapy in Korean heart failure patients: association between β adrenergic receptor polymorphism and bisoprolol therapy in heart failure (ABBA) study
por: Lee, Hae-Young, et al.
Publicado: (2016) -
Does atenolol differ from other β-adrenergic blockers?
por: Aursnes, Ivar, et al.
Publicado: (2007)